s6y
Company name or ticker
Search
IGC Pharma, Inc.
DEF 14A
Definitive proxy statements
Filed
Monday, July 8, 2024
Period
Aug 23, 2024
Accession number
0001185185-24-000674
Documents
FORM DEF 14A
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header